隶属于 zhangjiagang hwa-an investment co., ltd.
Lepu Biotechnology Co., Ltd. is an innovative biopharmaceutical company based in China and focusing on the field of cancer treatment for the world. We have developed a strong product pipeline focusing on oncolog-focused drug candidates, including clinical and preclinical ADCs, oncolytic virus drugs, and immunotherapy. We plan to commercialize the product pipeline domestically by building a professional sales and marketing team, and promote the product pipeline to overseas markets such as the US and Europe through cooperation with overseas companies.
相关临床试验
27
8 进行中
药物批准
2
批准总数
监管机构
1
监管机构数
成立时间
2018
进行中（未招募）
4
14.8%
已完成
5
18.5%
尚未招募
4
14.8%
招募中
11
40.7%
终止
1
3.7%
Unknown
2
7.4%
暂无资讯文章
